Orient Pharma Co., Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Taipei Taiwan (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2011
NCT01370811
First Marketed Drug
2014
carisoprodol (soma)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Orient Pharma Co., Ltd. | ORIENT PHARMA CO LTD